Bank OZK’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.45M | Sell |
25,055
-686
| -3% | -$152K | 1.92% | 8 |
|
|
2025
Q4 | $5.88M | Sell |
25,741
-305
| -1% | -$69.5K | 2.08% | 6 |
|
|
2025
Q3 | $6.03M | Sell |
26,046
-582
| -2% | -$119K | 2.13% | 6 |
|
|
2025
Q2 | $4.94M | Sell |
26,628
-389
| -1% | -$72.3K | 1.89% | 9 |
|
|
2025
Q1 | $5.66M | Sell |
27,017
-374
| -1% | -$72.7K | 2.36% | 5 |
|
|
2024
Q4 | $4.87M | Sell |
27,391
-970
| -3% | -$178K | 2.02% | 6 |
|
|
2024
Q3 | $5.6M | Sell |
28,361
-347
| -1% | -$64.8K | 2.31% | 5 |
|
|
2024
Q2 | $4.92M | Buy |
28,708
+419
| +1% | +$69.4K | 2.13% | 7 |
|
|
2024
Q1 | $5.15M | Sell |
28,289
-469
| -2% | -$80.8K | 2.31% | 7 |
|
|
2023
Q4 | $4.46M | Sell |
28,758
-580
| -2% | -$84.6K | 2.18% | 5 |
|
|
2023
Q3 | $4.37M | Sell |
29,338
-4,210
| -13% | -$618K | 2.4% | 4 |
|
|
2023
Q2 | $4.52M | Sell |
33,548
-3,707
| -10% | -$544K | 2.15% | 8 |
|
|
2023
Q1 | $5.94M | Sell |
37,255
-1,253
| -3% | -$192K | 2.94% | 4 |
|
|
2022
Q4 | $6.22M | Sell |
38,508
-70
| -0.2% | -$10.7K | 3.08% | 4 |
|
|
2022
Q3 | $5.18M | Buy |
38,578
+48
| +0.1% | +$6.89K | 2.81% | 3 |
|
|
2022
Q2 | $5.9M | Sell |
38,530
-554
| -1% | -$84.7K | 2.99% | 3 |
|
|
2022
Q1 | $6.34M | Sell |
39,084
-461
| -1% | -$67K | 2.72% | 3 |
|
|
2021
Q4 | $5.35M | Buy |
39,545
+70
| +0.2% | +$8.27K | 2.18% | 5 |
|
|
2021
Q3 | $4.26M | Sell |
39,475
-564
| -1% | -$64.4K | 1.93% | 11 |
|
|
2021
Q2 | $4.51M | Sell |
40,039
-449
| -1% | -$50.6K | 2% | 9 |
|
|
2021
Q1 | $4.38M | Buy |
40,488
+917
| +2% | +$98.1K | 2.02% | 9 |
|
|
2020
Q4 | $4.24M | Sell |
39,571
-355
| -0.9% | -$34.1K | 2.09% | 7 |
|
|
2020
Q3 | $3.5M | Buy |
39,926
+1,544
| +4% | +$145K | 1.87% | 11 |
|
|
2020
Q2 | $3.77M | Buy |
38,382
+2,263
| +6% | +$199K | 2.14% | 9 |
|
|
2020
Q1 | $2.75M | Sell |
36,119
-1,555
| -4% | -$132K | 1.51% | 13 |
|
|
2019
Q4 | $3.34M | Buy |
37,674
+1,838
| +5% | +$153K | 1.32% | 18 |
|
|
2019
Q3 | $2.71M | Sell |
35,836
-130
| -0.4% | -$8.91K | 1.2% | 19 |
|
|
2019
Q2 | $2.62M | Sell |
35,966
-522
| -1% | -$41K | 1.14% | 20 |
|
|
2019
Q1 | $2.94M | Sell |
36,488
-315
| -0.9% | -$25.8K | 1.28% | 15 |
|
|
2018
Q4 | $3.39M | Sell |
36,803
-125
| -0.3% | -$11K | 1.71% | 10 |
|
|
2018
Q3 | $3.49M | Sell |
36,928
-508
| -1% | -$48.2K | 1.39% | 12 |
|
|
2018
Q2 | $3.47M | Buy |
37,436
+1,220
| +3% | +$119K | 1.36% | 12 |
|
|
2018
Q1 | $3.43M | Sell |
36,216
-10,187
| -22% | -$1.12M | 1.36% | 11 |
|
|
2017
Q4 | $4.49M | Buy |
46,403
+10,128
| +28% | +$955K | 1.7% | 7 |
|
|
2017
Q3 | $3.22M | Sell |
36,275
-1,735
| -5% | -$132K | 1.33% | 11 |
|
|
2017
Q2 | $2.76M | Sell |
38,010
-1,715
| -4% | -$115K | 0.98% | 18 |
|
|
2017
Q1 | $2.59M | Sell |
39,725
-1,291
| -3% | -$81.2K | 0.84% | 19 |
|
|
2016
Q4 | $2.57M | Sell |
41,016
-50
| -0.1% | -$3.05K | 0.84% | 18 |
|
|
2016
Q3 | $2.59M | Buy |
41,066
+2,053
| +5% | +$133K | 0.94% | 18 |
|
|
2016
Q2 | $2.42M | Buy |
39,013
+7,845
| +25% | +$478K | 0.88% | 18 |
|
|
2016
Q1 | $1.78M | Buy |
31,168
+2,770
| +10% | +$154K | 0.65% | 22 |
|
|
2015
Q4 | $1.68M | Buy |
28,398
+4,573
| +19% | +$263K | 0.59% | 24 |
|
|
2015
Q3 | $1.3M | Buy |
23,825
+2,703
| +13% | +$176K | 0.49% | 30 |
|
|
2015
Q2 | $1.42M | Buy |
21,122
+3,140
| +17% | +$205K | 0.49% | 28 |
|
|
2015
Q1 | $1.05M | Buy |
17,982
+5,445
| +43% | +$329K | 0.38% | 37 |
|
|
2014
Q4 | $820K | Buy |
12,537
+741
| +6% | +$46.7K | 0.28% | 48 |
|
|
2014
Q3 | $682K | Buy |
11,796
+1,996
| +20% | +$111K | 0.25% | 53 |
|
|
2014
Q2 | $553K | Buy |
9,800
+1,835
| +23% | +$96.3K | 0.19% | 67 |
|
|
2014
Q1 | $409K | Sell |
7,965
-1,480
| -16% | -$74.8K | 0.15% | 78 |
|
|
2013
Q4 | $499K | Buy |
9,445
+1,425
| +18% | +$70K | 0.19% | 65 |
|
|
2013
Q3 | $358K | Buy |
+8,020
| New | +$356K | 0.16% | 74 |
|
Other funds holding ABBV
VCM
VPM
Bank OZK's ABBV Position: Q1 2026 in Review
Bank OZK reduced its AbbVie (ABBV) stake by 2.7% in Q1 2026, selling an estimated $152K and leaving 25,055 shares worth $5.45M. The position accounts for 1.92% of the portfolio, ranked #8.
Bank OZK first reported a position in ABBV in Q3 2013 and has held it in 51 quarters since. The position peaked at $6.34M in Q1 2022. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Bank OZK held 25,055 shares of AbbVie worth $5.45M as of Q1 2026.
- Bank OZK sold 686 AbbVie shares in Q1 2026, an estimated $152K.
- AbbVie made up 1.92% of Bank OZK's portfolio in Q1 2026, its #8 holding.
- Bank OZK first reported a position in AbbVie in Q3 2013 and has held it in 51 quarters since.
- Bank OZK's AbbVie position peaked at $6.34M in Q1 2022.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Bank OZK's 13F filing for Q1 2026, filed 13 May 2026.